Evolving function and potential of pancreatic alpha cells

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 29, Issue 6, 2015, Pages 859-871

  Stanojevic, Violeta ^a   Habener, Joel F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

alpha cells; beta cells; diabetes; GLP 1; proglucagon; transdifferentiation

Indexed keywords

GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCAGON RECEPTOR;

CELL DAMAGE; CELL DIFFERENTIATION; CELL GROWTH; CELL SURVIVAL; CELL TRANSDIFFERENTIATION; DIABETES MELLITUS; ENDOCRINE CELL; GROWTH; HUMAN; METABOLIC STRESS; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL HYPERPLASIA; PROTEIN EXPRESSION; REVIEW; WELLBEING; ANIMAL; CYTOLOGY; METABOLISM; SIGNAL TRANSDUCTION;

ANIMALS; CELL TRANSDIFFERENTIATION; GLUCAGON; GLUCAGON-SECRETING CELLS; HUMANS; INSULIN-SECRETING CELLS; SIGNAL TRANSDUCTION;

EID: 84970938038     PISSN: 1521690X     EISSN: 15321908     Source Type: Journal    
DOI: 10.1016/j.beem.2015.10.002     Document Type: Review

References (78)

1. B. Ahrén Glucagon-early breakthroughs and recent discoveries Peptides 67 2015 74 81
2. R.H. Unger Glucagon physiology and pathophysiology N Engl J Med 285 1971 443 449
3. A.T. Kharroubi, and H.M. Darwish Diabetes mellitus: the epidemic of the century World J Diab 6 2015 850 867
4. S. Cornell Continual evolution of type 2 diabetes: an update on pathophysiology and emerging treatment options Ther Clin Risk Manag 11 2015 621 632
5. P.A. Lysy, G.C. Weir, and S. Bonner-Weir Making β cells from adult cells within the pancreas Curr Diab Rep 13 2013 695 703
6. L. Bouwens, I. Houbracken, and J.K. Mfopou The use of stem cells for pancreatic regeneration in diabetes mellitus Nat Rev Endocrinol 9 2013 598 606
7. P. Collombat, X. Xu, P. Ravassard, and et al. The ectopic expression of Pax4 in the mouse pancreas converts progenitor cells into alpha and subsequently beta cells Cell 138 2009 449 462
8. F. Thorel, V. Népote, I. Avril, and et al. Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss Nature 464 2010 1149 1154
9. C.H. Chung, E. Hao, R. Piran, and et al. Pancreatic beta cell neogenesis by direct conversion from mature alpha cells Stem Cells 28 2010 1630 1638
10. Y.P. Yang, F. Thorel, D.F. Boyer, and et al. Context-specific α- to-β-cell reprogramming by forced Pdx1 expression Genes Dev 25 2011 1680 1685
11. K. Al-Hasani, A. Pfeifer, M. Courtney, and et al. Adult duct-lining cells can reprogram into β-like cells able to counter repeated cycles of toxin-induced diabetes Dev Cell 26 2013 86 100
12. S. Chera, D. Baronnier, L. Ghila, and et al. Diabetes recovery by age-dependent conversion of pancreatic δ-cells into insulin producers Nature 514 2014 503 507
13. R.H. Unger Glucagon physiology and pathophysiology in the light of new advances Diabetologia 28 1985 574 578
14. J. Gromada, I. Franklin, and C.B. Wollheim Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains Endocr Rev 28 2007 84 116
15. R.H. Unger, and A.D. Cherrington Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover J Clin Invest 122 2012 4 12
16. J.F. Habener, and V. Stanojevic α-cell role in β-cell generation and regeneration Islets 4 2012 188 198
17. J.F. Habener, and V. Stanojevic Alpha cells come of age Trends Endocrinol Metab 24 2013 153 163
18. R. Yu Pancreatic α-cell hyperplasia: facts and myths J Clin Endocrinol Metab 99 2014 748 756
19. M.J. Charron, and P.M. Vuguin Lack of glucagon receptor signaling and its implications beyond glucose homeostasis J Endocrinol 224 2015 R123 R130
20. A. Lund, J.I. Bagger, M. Christensen, and et al. Glucagon and type 2 diabetes: the return of the alpha cell Curr Diab Rep 14 2014 555
21. T.J. Kieffer, and J.F. Habener The glucagon-like peptides Endocr Revs 20 1999 876 913
22. D.A. Sandoval, and D.A. D'Alessio Physiology of proglucagon peptides: role of glucagon and GLP-1 in health and disease Physiol Rev 95 2015 513 548
23. J.E. Campbell, and D.J. Drucker Pharmacology, physiology, and mechanisms of incretin hormone action Cell Metab 17 2013 819 837
24. D. Bataille Pro-protein convertases in intermediary metabolism: islet hormones, brain/gut hormones and integrated physiology J Mol Med Berl 85 2007 673 684
25. E. Tomas, and J.F. Habener Insulin-like actions of glucagon-like peptide-1: a dual receptor hypothesis Trends Endocrinol Metab 21 2010 59 67
26. O. Cabrera, D.M. Berman, N.S. Kenyon, and et al. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function Proc Natl Acad Sci U. S. A 103 2006 2334 2339
27. D. Bosco, M. Armanet, P. Morel, and et al. Unique arrangement of alpha- and beta-cells in human islets of Langerhans Diabetes 59 2010 1202 1210
28. R.H. Unger, and L. Orci Paracrinology of islets and the paracrinopathy of diabetes Proc Natl Acad Sci U. S. A 107 2010 16009 16012
29. J. Jonsson, L. Carlsson, T. Edlund, and et al. Insulin-promoter-factor 1 is required for pancreas development in mice Nature 371 1994 606 609
30. T. van der Meulen, and M.O. Huising Role of transcription factors in the transdifferentiation of pancreatic islet cells J Mol Endocrinol 54 2015 R103 R117
31. P.L. Herrera Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages Development 127 2000 2317 2322
32. P. Collombat, X. Xu, H. Heimberg, and et al. Pancreatic beta-cells: from generation to regeneration Semin Cell Dev Biol 21 2010 838 844
33. C. Talchai, S. Xuan, H.V. Lin, and et al. Pancreatic β cell dedifferentiation as a mechanism of diabetic β cell failure Cell 150 2012 1223 1234
34. M. Courtney, A. Pfeifer, K. Al-Hasani, and et al. In vivo conversion of adult α-cells into β-like cells: a new research avenue in the context of type 1 diabetes Diabetes Obes Metab 13 Suppl 1 2011 47 52
35. M. Courtney, E. Gjernes, N. Druelle, and et al. The inactivation of Arx in pancreatic α-cells triggers their neogenesis and conversion into functional β-like cells PLoS Genet 9 2013 e1003934
36. P. Collombat, A. Mansouri, J. Hecksher-Sorensen, and et al. Opposing actions of Arx and Pax4 in endocrine pancreas development Genes Dev 17 2003 2591 2603
37. C.L. Wilcox, N.A. Terry, E.R. Walp, and et al. Pancreatic α-cell specific deletion of mouse Arx leads to α-cell identity loss PLoS One 8 2013 e66214
38. T. Gao, B. McKenna, C. Li, and et al. Pdx1 maintains β cell identity and function by repressing an α cell program Cell Metab 19 2014 259 271
39. P. Collombat, J. Hecksher-Sørensen, J. Krull, and et al. Embryonic endocrine pancreas and mature beta cells acquire alpha and PP cell phenotypes upon Arx misexpression J Clin Invest 117 2007 961 970
40. S. Dhawan, S. Georgia, S.I. Tschen, and et al. Pancreatic beta cell identity is maintained by DNA methylation-mediated repression of Arx Dev Cell 20 2011 419 429
41. N.C. Bramswig, L.J. Everett, J. Schug, and et al. Epigenomic plasticity enables human pancreatic α to β cell reprogramming J Clin Invest 123 2013 1275 1284
42. Z. Wang, N.W. York, C.G. Nichols, and et al. Pancreatic β cell dedifferentiation in diabetes and redifferentiation following insulin therapy Cell Metab 19 2014 872 882
43. R.P. Robertson, J. Harmon, P.O. Tran, and et al. Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes Diabetes 53 Suppl. 1 2004 S119 S124
44. M.G. Vander Heiden, L.C. Cantley, and C.B. Thompson Understanding the Warburg effect: the metabolic requirements of cell proliferation Science 324 2009 1029 1033
45. Z. Li, F.A. Karlsson, and S. Sandler Islet loss and alpha cell expansion in type 1 diabetes induced by multiple low-dose streptozotocin administration in mice J Endocrinol 165 2000 93 99
46. Y. Nie, M. Nakashima, P.L. Brubaker, and et al. Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats J Clin Invest 105 2000 955 965
47. S. Thyssen, F. Arany, and D.J. Hill Ontogeny of regeneration of beta cells in the neonatal rat after treatment with streptozotocin Endocrinology 147 2006 2346 2356
48. Y. Lee, M.Y. Wang, X.Q. Du, and et al. Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice Diabetes 60 2011 391 397
49. R.D. Wideman, I.L. Yu, T.D. Webber, and et al. Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 Proc Natl Acad Sci U. S. A 103 2006 13468 13473
50. G. Kilimnik, A. Kim, D.F. Steiner, and et al. Intraislet production of GLP-1 by activation of prohormone convertase 1/3 in pancreatic α-cells in mouse models of ß-cell regeneration Islets 2 2010 149 155
51. A.M. Hansen, T.B. Bödvarsdottir, D.N. Nordestgaard, and et al. Upregulation of alpha cell glucagon-like peptide 1 (GLP-1) in Psammomys obesus-an adaptive response to hyperglycaemia? Diabetologia 54 2011 1379 1387
52. N.M. Whalley, L.E. Pritchard, D.M. Smith, and et al. Processing of proglucagon to GLP-1 in pancreatic alpha-cells: is this a paracrine mechanism enabling GLP-1 to act on beta cells? J Endocrinol 211 2011 99 106
53. Z. Liu, V. Stanojevic, S. Avadhani, and et al. Stromal cell-derived factor-1 (SDF-1)/chemokine (C-X-C motif) receptor 4 (CXCR4) axis activation induces intra-islet glucagon-like peptide-1 (GLP-1) production and enhances beta cell survival Diabetologia 54 2011 2067 2076
54. A.K. Linnemann, J.C. Neuman, T.J. Battiola, and et al. Glucagon-like Peptide-1 regulates cholecystokinin production in β-cells to protect from apoptosis Mol Endocrinol 29 2015 978 987
55. P. Marchetti, R. Lupi, M. Bugliani, and et al. A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets Diabetologia 55 2012 3262 3272
56. L.A. O'Reilly, D. Gu, N. Sarvetnick, and et al. alpha-Cell neogenesis in an animal model of IDDM Diabetes 46 1997 599 606
57. N. Ogawa, J.F. List, J.F. Habener, and et al. Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4 Diabetes 53 2004 1700 1705
58. T. Rydgren, A. Börjesson, A. Carlsson, and et al. Elevated glucagon-like peptide-1 plasma levels, as a possible adaptive response, in diabetic NOD mice Biochem Biophys Res Commun 423 2012 583 587
59. A.E. Butler, M. Campbell-Thompson, T. Gurlo, and et al. Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors Diabetes 62 2013 2595 2604
60. H. Ellingsgaard, I. Hauselmann, B. Schuler, and et al. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells Nat Med 17 2011 1481 1489
61. M.E. Wilson, J.A. Kalamaras, and M.S. German Expression pattern of IAPP and prohormone convertase 1/3 reveals a distinctive set of endocrine cells in the embryonic pancreas Mech Dev 115 2002 171 176
62. M.H. Kedees, Y. Guz, P.M. Vuguin, and et al. Nestin expression in pancreatic endocrine and exocrine cells of mice lacking glucagon signaling Dev Dyn 236 2007 1126 1133
63. R.W. Gelling, X.Q. Du, D.S. Dichmann, and et al. Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice Proc Natl Acad Sci U. S. A 100 2003 1438 1443
64. S. Ali, B.J. Lamont, M.J. Charron, and et al. Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis J Clin Invest 121 2011 1917 1929
65. K.W. Sloop, J.X. Cao, A.M. Siesky, and et al. Hepatic and glucagon-like peptide-1-mediated reversal of diabetes by glucagon receptor antisense oligonucleotide inhibitors J Clin Invest 113 2004 1571 1581
66. Y. Hayashi, M. Yamamoto, H. Mizoguchi, and et al. Mice deficient for glucagon gene-derived peptides display normoglycemia and hyperplasia of islet {alpha}-cells but not of intestinal L-cells Mol Endocrinol 23 2009 1990 1999
67. M. Furuta, H. Yano, A. Zhou, and et al. Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2 Proc Natl Acad Sci U. S. A 94 1997 6646 6651
68. W. Gu, H. Yan, K.A. Winters, and et al. Long-term inhibition of the glucagon receptor with a monoclonal antibody in mice causes sustained improvement in glycemic control, with reversible alpha-cell hyperplasia and hyperglucagonemia J Pharmacol Exp Ther 331 2009 871 881
69. M. Chen, O. Gavrilova, W.Q. Zhao, and et al. Increased glucose tolerance and reduced adiposity in the absence of fasting hypoglycemia in mice with liver-specific Gs alpha deficiency J Clin Invest 115 2005 3217 3227
70. C. Longuet, A.M. Robledo, E.D. Dean, and et al. Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor Diabetes 62 2013 1196 1205
71. C. Zhou, D. Dhall, N.N. Nissen, and et al. Homozygous P86S mutation of the human glucagon receptor is associated with hyperglucagonemia, alpha cell hyperplasia, and islet cell tumor Pancreas 38 2009 941 946
72. R. Yu, D. Dhall, N.N. Nissen, C. Zhou, and S.G. Ren Pancreatic neuroendocrine tumors in glucagon receptor-deficient mice PLoS One. 6 8 2011 e23397
73. M.B. Lucas, V.E. Yu, and R. Yu Mahvash disease: pancreatic neuroendocrine tumor syndrome caused by inactivating glucagon receptor mutation J Mol Genet Med 7 2013 84
74. Y. Takano, K. Kasai, Y. Takagishi, and et al. Pancreatic neuroendocrine tumors in mice deficient in proglucagon-derived peptides PLoS One 10 2015 e0133812
75. R.H. Unger, P. Raskin, C.B. Srikant, and et al. Glucagon and the A cells Recent Prog Horm Res 33 1976 477 517
76. G.R. Bebernitz, and H.F. Schuster The impact of fatty acid oxidation on energy utilization: targets and therapy Curr Pharm Des 8 2002 1199 1227
77. M.Y. Wang, H. Yan, Z. Shi, and et al. Glucagon receptor antibody completely suppresses type 1 diabetes phenotype without insulin by disrupting a novel diabetogenic pathway Proc Natl Acad Sci U. S. A 112 2015 2503 2508
78. A.S. Hancock, A. Du, J. Liu, and et al. Glucagon deficiency reduces hepatic glucose production and improves glucose tolerance in adult mice Mol Endocrinol 24 2010 1605 1614